| Literature DB >> 31337298 |
Frank A Wollenweber1,2, Steffen Tiedt1, Anna Alegiani3, Burkhard Alber4, Christopher Bangard5, Jörg Berrouschot6, Felix J Bode7, Tobias Boeckh-Behrens8, Georg Bohner9, Albrecht Bormann10, Michael Braun11, Franziska Dorn12, Bernd Eckert13, Fabian Flottmann14, Gerhard F Hamann4, Karl-Heinz Henn15, Moriz Herzberg12, Andreas Kastrup16, Lars Kellert2, Christoffer Kraemer17, Lars Krause18, Manuel Lehm8, Jan Liman19, Stephan Lowens20, Anastasios Mpotsaris21, Panagiotis Papanagiotou22, Martina Petersen18, Gabor C Petzold7,23, Waltraud Pfeilschifter24, Marios-Nikos Psychogios25,26, Arno Reich27, Regina von Rennenberg28, Joachim Röther29, Jan-Hendrik Schäfer24, Eberhard Siebert9, Andreas Siedow15, Laszlo Solymosi30, Sven Thonke31, Marlies Wagner32, Silke Wunderlich33, Sarah Zweynert28, Christian H Nolte28, Christian Gerloff3, Götz Thomalla3, Martin Dichgans1,23, Jens Fiehler14.
Abstract
Background and Purpose- Endovascular treatment for large vessel occlusion in ischemic stroke has proven to be effective in large clinical trials. We aimed to provide real-world estimates of endovascular treatment reperfusion rates and functional outcome on a countrywide scale. Methods- Two thousand seven hundred ninety-four patients with large vessel occlusion were included into an investigator-initiated, industry-independent, prospective registry in 25 sites in Germany between June 2015 and April 2018. The primary outcome was the score on the modified Rankin Scale ranging from zero (no symptoms) to 6 (death) at 3 months. Secondary analyses included the prediction of a good outcome (modified Rankin Scale, 0-2). Dichotomized analyses of predictors were performed using logistic regression adjusted for potential confounders. Results- Median age was 75 years (interquartile range, 64-82); median National Institutes of Health Stroke Scale score was 15 (interquartile range, 10-19). Vessel occlusion was in the anterior circulation in 2265 patients (88%) and in the posterior circulation in 303 patients (12%). Intravenous alteplase before endovascular treatment was given in 1457 patients (56%). Successful reperfusion was achieved in 2143 subjects (83%). At 3 months, 854 patients (37%) showed a good outcome; mortality was 29%. There was no difference between anterior and posterior circulation occlusions (P=0.27). Significant predictors for a good outcome were younger age (odds ratio [OR], 1.06; 95% CI, 1.05-1.07), no interhospital transfer (OR, 1.39; 95% CI, 1.03-1.88), lower stroke severity (OR, 1.10; 95% CI, 1.08-1.13), smaller infarct size (OR, 1.26; 95% CI, 1.15-1.39), alteplase use (OR, 1.49; 95% CI, 1.08-2.06), and reperfusion success (OR, 1.69; 95% CI, 1.45-1.96). Conclusions- High rates of favorable outcome can be achieved on a countrywide scale by endovascular treatment. Mortality appears to be greater in the daily routine than otherwise reported by authors of large randomized trials. There were no outcome differences between the anterior and posterior circulation. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT03356392.Entities:
Keywords: Germany; humans; ischemic stroke; registries; reperfusion; thrombectomy
Year: 2019 PMID: 31337298 DOI: 10.1161/STROKEAHA.119.026005
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914